scorecardresearch

INDUSTRY

Roche says it plans to offer the drug to patients in India at a much discounted price. Photo: Reuters

Roche's oral therapy 'Evrysdi' to provide cost-effective alternative against fatal genetic disorder SMA in India

Jul 29, 2021

Until now, SMA in India was curable only with the two most expensive and imported gene therapies -- Spinraza and Zolgensma -- from Biogen-Ionis and Novartis. Treatment for SMA costs over Rs 16-18 crore in India

Jhunjhunwala has said that he will launch an ultra-low-cost carrier or ULCC which means that he plans to capture the mass market

Decoding Rakesh Jhunjhunwala's airline venture Akasa's flight plan

Jul 29, 2021

India is an under-penetrated market when it comes to aviation. Just a fraction of the population currently travels by air. Airlines like IndiGo are already talking about taking away the market from railways by offering competitive fares

The cards will initially be available to LIC policyholders, agents, as well as employees of the corporation and its subsidiaries (Source: Twitter)

LIC Cards Services, IDBI Bank launch RuPay credit cards Lumine, Eclat: check out full details

Jul 29, 2021

Lumine and Eclat Cardholders will earn 'Welcome Bonus Delight Points' of 1,000 and 1,500, respectively, on spending Rs 10,000 in 60 days from the date of the card issued

Kotak Mahindra Bank managing director and chief executive Uday Kotak

Covid-19 has brought everlasting changes in ways consumers, businesses function: Uday Kotak

Jul 29, 2021

There are some significant structural changes that are taking place in the way we live and work, the way we bank, shop and interact with others, Uday Kotak writes to the shareholders

Mudra loans, which are given as business loans to small businesses, have seen a gradual rise in the gross NPAs over the last few years

SBI's Mudra loan NPAs jump to 23% despite Covid restructuring package, collateral-free guarantee

Jul 29, 2021

Outstanding Mudra loans in SBI's books were Rs 26,302 crore against gross NPAs of over Rs 6,000 crore in 2020-21

The Reserve Bank said it has cancelled the licence of the bank as it does not have adequate capital and earning prospects

RBI cancels licence of Goa-based The Madgaum Urban Cooperative Bank; bars it from conducting ‘banking’ operations

Jul 29, 2021

RBI says about 99 per cent of depositors will receive full amounts of their deposits from Deposit Insurance and Credit Guarantee Corporation

Cement industry's growth in eastern India, for long, was unimpressive (Source: Reuters)

Cement firms look East! Shree Cement, Ultratech, others eye expansion

Jul 29, 2021

Earlier in the week, Shree Cement said it was investing over Rs 600 crore in West Bengal to set up a cement grinding unit. Other players are also making swift moves

The Centre is currently in the process of selling Air India

Air India sold its 115 properties for Rs 738 crore since 2015 to offset debt says govt

Jul 29, 2021

According to the decision of Air India Specific Alternative Mechanism (AISAM) in 2018, disinvestment-bound Air India has been monetising its immovable assets to offset its debt

Air India will operate additional international flights as part of the Vande Bharat mission

Air India announces new flights to Maldives, Malaysia: Check out schedule, prices

Jul 29, 2021

As Maldives and Malaysia have eased travel restrictions with India, Air India has announced new international flights connecting Indian cities with them

Power demand growth highest in three fiscals

Power demand to grow 5%, fastest in three fiscals: CRISIL

Jul 29, 2021

On-year growth of over 5 per cent or 75 BUs would have been higher by around 100 bps if the second wave had not impacted the industry, said CRISIL

The AZD1222 vaccine is pending a US Food and Drug Administration (USFDA) application

COVID-19 vaccine: AstraZeneca to apply for approval in US later this year

Jul 29, 2021

As part of second-quarter financial results released on Thursday, the approvals timetable indicates a USFDA approval application for COVID-19 Vaccine AstraZeneca SARS-CoV-2 (US) later in the year